Anti-2019-nCoV S-cIgG1 Neutralizing Antibody (8A5)

Vendor: ELK Biotechnology

SKU: EPT085

$399.00 USD
Shipping calculated at checkout.

Documents

Manuals

Available in stock (100)

  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.

Product Overview

Biological activity
Immobilized 2019-nCoV S Protein RBD-SD1-His(Cat#DRA42)at 2μg/ml (100μl/well) can bind Anti-2019-nCoV S-cIgG1 Antibody (8A5)(Cat#DA036). The ED50 of Anti-2019-nCoV S-cIgG1 Antibody (8A5)(Cat#DA036)is 19.74 ng/ml.
Delivery condition
The product is shipped on dry ice pack.Upon receipt, store it immediately at the temperature listed below.
Description
The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
Storage
24 months from manufacturing at <-20 °C; 1 month, 2 to 8 °C under sterile conditions.
Anti-2019-nCoV S-cIgG1 Neutralizing Antibody (8A5)

Anti-2019-nCoV S-cIgG1 Neutralizing Antibody (8A5)

$399.00 USD